Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
"便秘1号" appears to be a code or brand name for a Chinese medicine product intended for the treatment of constipation, specifically chronic functional constipation. Based on the context of Chinese drug naming conventions and clinical guidelines, "便秘1号" is likely a proprietary traditional Chinese medicine (TCM) formulation developed for use in chronic constipation. Such products are typically multi-ingredient herbal combinations designed according to TCM principles, aiming to promote bowel movement by regulating intestinal function and moistening the intestines. The exact composition and mechanism of action are not specified in available public sources; however, TCM formulations for constipation often include herbs with laxative effects (such as rhubarb or hemp seed), ingredients that nourish yin or moisten dryness, and agents that regulate qi flow. There is no evidence from the provided sources that "便秘1号" refers to any internationally recognized pharmaceutical ingredient such as lubiprostone, polyethylene glycol, lactulose, linaclotide, or prucalopride[1][2][3]. Instead, it fits within the category of multi-ingredient TCM products used in China for this indication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 便秘1号.